Bumrungrad Hospital Public Company Limited (BUHPF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bumrungrad Hospital Public Company Limited (BUHPF) with AI Score 47/100 (Weak). Bumrungrad Hospital Public Company Limited operates healthcare facilities in Thailand and internationally, offering a wide range of medical services. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Bumrungrad Hospital Public Company Limited (BUHPF) Healthcare & Pipeline Overview
Bumrungrad Hospital, a leading healthcare provider based in Thailand, offers comprehensive medical services with a focus on international patients. Operating with 580 beds and numerous specialized clinics, the company distinguishes itself through high-quality care and advanced medical technologies, reflected in its strong profit margin of 29.8% and a substantial dividend yield of 8.41%.
Investment Thesis
Bumrungrad Hospital presents a compelling investment case due to its established market position, strong financial performance, and growth opportunities in the healthcare sector. The company's high profit margin of 29.8% and dividend yield of 8.41% indicate financial stability and shareholder value. Key growth catalysts include increasing demand for healthcare services in Thailand and the expansion of its international patient base. The company's focus on specialized medical treatments and advanced technologies positions it favorably in a competitive market. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations affecting patient affordability. The company's low beta of -0.07 suggests it is less volatile than the market, potentially offering a more stable investment option. Bumrungrad's ability to maintain its competitive edge through continuous innovation and service excellence will be crucial for sustained growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $4.49B reflects Bumrungrad's significant presence and value in the healthcare industry.
- P/E Ratio of 17.64 suggests a reasonable valuation compared to its earnings.
- Profit Margin of 29.8% demonstrates strong operational efficiency and profitability.
- Gross Margin of 51.8% indicates effective cost management and pricing strategies.
- Dividend Yield of 8.41% provides a substantial return to investors, highlighting the company's commitment to shareholder value.
Competitors & Peers
Strengths
- Strong brand reputation and international accreditation.
- Comprehensive range of medical services and specialized centers.
- Experienced medical professionals and staff.
- Strategic location in Bangkok, a hub for medical tourism.
Weaknesses
- Dependence on international patients, making it vulnerable to travel restrictions and economic fluctuations.
- High operating costs associated with maintaining international standards.
- Competition from other healthcare providers in the region.
- Potential regulatory challenges in the healthcare industry.
Catalysts
- Upcoming: Expansion of specialized medical centers to attract more patients.
- Ongoing: Increasing demand for healthcare services in Thailand and the region.
- Ongoing: Growth in medical tourism and international patient services.
- Upcoming: Adoption of advanced medical technologies to improve treatment outcomes.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
Risks
- Potential: Economic downturns affecting patient affordability and demand for medical services.
- Potential: Changes in healthcare regulations and policies.
- Ongoing: Increased competition from other healthcare providers.
- Potential: Political instability and security risks in the region.
- Ongoing: Dependence on international patients, making it vulnerable to travel restrictions.
Growth Opportunities
- Expansion of International Patient Services: Bumrungrad has a significant opportunity to further expand its services to international patients, particularly from regions with limited access to advanced medical treatments. By strengthening its marketing efforts and partnerships with international healthcare providers, Bumrungrad can attract a larger patient base seeking specialized medical care in Thailand. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth avenue for Bumrungrad.
- Development of Specialized Medical Centers: Investing in the development of specialized medical centers focused on specific medical disciplines, such as oncology, cardiology, and orthopedics, can attract more patients seeking advanced treatments. By offering comprehensive care within these specialized centers, Bumrungrad can enhance its reputation as a center of medical excellence and attract both domestic and international patients. This targeted approach allows for efficient resource allocation and specialized expertise.
- Adoption of Advanced Medical Technologies: Integrating advanced medical technologies, such as robotic surgery, AI-powered diagnostics, and telemedicine, can improve treatment outcomes and enhance patient experience. By investing in these technologies, Bumrungrad can attract patients seeking cutting-edge medical solutions and differentiate itself from competitors. The global market for AI in healthcare is expected to reach $34 billion by 2025, indicating a significant opportunity for technological integration.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other healthcare providers, insurance companies, and medical tourism agencies can expand Bumrungrad's reach and patient base. Acquiring smaller hospitals or clinics can also provide access to new markets and specialized services. These collaborations can enhance Bumrungrad's market presence and service offerings, driving revenue growth and market share.
- Enhancement of Digital Healthcare Services: Expanding digital healthcare services, such as online consultations, remote monitoring, and digital health records, can improve patient access and convenience. By offering these services, Bumrungrad can cater to a wider patient base and enhance patient engagement. The global digital health market is projected to reach $660 billion by 2025, indicating a significant opportunity for Bumrungrad to leverage digital technologies to enhance its services.
Opportunities
- Expansion of services to new markets and regions.
- Development of specialized medical centers and advanced treatments.
- Adoption of digital healthcare technologies and telemedicine.
- Strategic partnerships and acquisitions to expand market reach.
Threats
- Economic downturns affecting patient affordability and demand for medical services.
- Changes in healthcare regulations and policies.
- Increased competition from other healthcare providers.
- Political instability and security risks in the region.
Competitive Advantages
- Established reputation and brand recognition as a leading healthcare provider in Thailand.
- Accreditation and international standards of medical care.
- Comprehensive range of medical services and specialized centers.
- Strategic location in Bangkok, a hub for medical tourism.
About BUHPF
Founded in 1980 and headquartered in Bangkok, Thailand, Bumrungrad Hospital Public Company Limited has evolved into a prominent healthcare provider, offering a broad spectrum of medical services both domestically and internationally. The company operates a large medical center equipped with diagnostic, therapeutic, and intensive care facilities. Its extensive network includes approximately 56 outpatient clinics and centers, covering a wide array of specialties such as allergy, cardiology, oncology, orthopedics, and women's health. Bumrungrad distinguishes itself by catering to a diverse patient base, including a significant number of international patients seeking specialized medical treatments and services. Beyond its core hospital operations, Bumrungrad is involved in real estate asset management, clinical research services, and the distribution of pharmaceutical and medical goods through specialized stores. The company also operates a personnel development and training center to ensure high standards of healthcare service delivery and manages a patient referral service business to facilitate access to its medical expertise. With 580 beds, Bumrungrad Hospital is equipped to handle a large volume of patients, providing comprehensive care across various medical disciplines.
What They Do
- Operates a large medical center in Bangkok, Thailand.
- Provides diagnostic, therapeutic, and intensive care facilities.
- Offers a wide range of outpatient clinics and centers specializing in various medical disciplines.
- Caters to both domestic and international patients.
- Engages in real estate asset management related to healthcare facilities.
- Provides clinical research services.
- Distributes pharmaceutical and medical goods through specialized stores.
- Operates a personnel development and training center for healthcare services.
Business Model
- Generates revenue through patient fees for medical services.
- Attracts international patients seeking specialized treatments.
- Operates outpatient clinics and centers for various medical specialties.
- Distributes pharmaceutical and medical goods through specialized stores.
Industry Context
Bumrungrad Hospital operates within the growing medical care facilities industry, driven by increasing healthcare demand in Thailand and the broader Southeast Asia region. The industry is characterized by technological advancements, rising medical tourism, and an aging population requiring more healthcare services. Competition includes both local and international hospitals, with key players focusing on specialized treatments and patient experience. Bumrungrad distinguishes itself through its international accreditation and focus on medical tourism, catering to a global patient base seeking high-quality healthcare services. The company's ability to adapt to changing healthcare regulations and technological advancements will be crucial for maintaining its competitive edge.
Key Customers
- Domestic patients in Thailand seeking medical care.
- International patients seeking specialized treatments and medical tourism.
- Insurance companies and healthcare providers.
- Patients seeking outpatient services and specialized medical centers.
Financials
Chart & Info
Bumrungrad Hospital Public Company Limited (BUHPF) stock price: Price data unavailable
Latest News
No recent news available for BUHPF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BUHPF.
Price Targets
Wall Street price target analysis for BUHPF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BUHPF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Artirat Charukitpipat
CEO
Artirat Charukitpipat serves as the CEO of Bumrungrad Hospital Public Company Limited. Her background includes extensive experience in healthcare management and strategic leadership. Prior to her role as CEO, she held various leadership positions within the company, contributing to its growth and development. She possesses a strong understanding of the healthcare industry and a commitment to delivering high-quality patient care. Her expertise spans across operational management, strategic planning, and business development within the healthcare sector.
Track Record: Under Artirat Charukitpipat's leadership, Bumrungrad Hospital has continued to strengthen its position as a leading healthcare provider in Thailand and internationally. She has focused on enhancing patient experience, expanding medical services, and adopting advanced technologies. Her strategic decisions have contributed to the company's financial stability and growth, as evidenced by its consistent profitability and market capitalization. She has also overseen the implementation of various initiatives to improve operational efficiency and enhance the company's competitive edge.
BUHPF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bumrungrad Hospital Public Company Limited (BUHPF) may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting or regulatory oversight, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ. This tier often includes companies that are distressed, undergoing restructuring, or have chosen not to comply with higher reporting standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of readily available financial information increases investment risk.
- Low Liquidity: Limited trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Regulatory Oversight: Reduced regulatory scrutiny compared to major exchanges increases the risk of fraud or mismanagement.
- Price Volatility: Low trading volume can lead to significant price fluctuations.
- Information Asymmetry: Difficulty in obtaining reliable information about the company's operations and financial performance.
- Verify the company's registration and legal status.
- Attempt to locate and review any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Consult with a financial advisor to evaluate the risks and potential rewards.
- Check for any news or reports about the company's operations and performance.
- Understand the OTC Other tier and its implications for investor protection.
- Established operations as a healthcare provider in Thailand.
- Market capitalization of $4.49B suggests a significant enterprise.
- Positive profit margin of 29.8% indicates profitability.
- Dividend yield of 8.41% suggests a commitment to shareholder returns.
- Operating history since 1980 indicates some level of stability.
Bumrungrad Hospital Public Company Limited Stock: Key Questions Answered
What does Bumrungrad Hospital Public Company Limited do?
Bumrungrad Hospital Public Company Limited operates as a leading healthcare provider in Thailand, offering a comprehensive range of medical services to both domestic and international patients. The company's business model revolves around providing high-quality medical care through its network of specialized clinics and centers, catering to various medical disciplines. Bumrungrad generates revenue through patient fees for medical services, attracting international patients seeking specialized treatments, and operating outpatient clinics and centers for various medical specialties. The company also distributes pharmaceutical and medical goods through specialized stores, enhancing its service offerings.
What do analysts say about BUHPF stock?
Analyst consensus on BUHPF stock is currently unavailable due to limited coverage. However, key valuation metrics such as the P/E ratio of 17.64 and a dividend yield of 8.41% offer insights into the company's financial performance. Growth considerations include the increasing demand for healthcare services in Thailand and the expansion of its international patient base. Investors should conduct their own due diligence and consider the risks associated with investing in an OTC-listed company with limited financial disclosure before making any investment decisions. Further AI analysis is pending for BUHPF.
What are the main risks for BUHPF?
The main risks for Bumrungrad Hospital Public Company Limited include economic downturns affecting patient affordability and demand for medical services, changes in healthcare regulations and policies, and increased competition from other healthcare providers in the region. The company's dependence on international patients also makes it vulnerable to travel restrictions and economic fluctuations. Additionally, as an OTC-listed company, BUHPF faces risks associated with limited financial disclosure, low liquidity, and reduced regulatory oversight, which can increase the potential for price volatility and information asymmetry. Investors should carefully assess these risks before investing in BUHPF.
What are the key factors to evaluate for BUHPF?
Bumrungrad Hospital Public Company Limited (BUHPF) currently holds an AI score of 47/100, indicating low score. Key strength: Strong brand reputation and international accreditation.. Primary risk to monitor: Potential: Economic downturns affecting patient affordability and demand for medical services.. This is not financial advice.
How frequently does BUHPF data refresh on this page?
BUHPF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BUHPF's recent stock price performance?
Recent price movement in Bumrungrad Hospital Public Company Limited (BUHPF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand reputation and international accreditation.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BUHPF overvalued or undervalued right now?
Determining whether Bumrungrad Hospital Public Company Limited (BUHPF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BUHPF?
Before investing in Bumrungrad Hospital Public Company Limited (BUHPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for more detailed insights.